Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sandhiya Ramachandran"'
Autor:
Sandhiya Ramachandran, Swetha Loganathan, Vinnie Cheeran, Soniya Charles, Ganesh Munuswamy-Ramanujan, Mohankumar Ramasamy, Vijay Raj, Kanchana Mala
Publikováno v:
Leukemia Research Reports, Vol 9, Iss , Pp 28-35 (2018)
Doxorubicin (DOX) is an antitumor drug, associated with cardiomyopathy. Strategies to address DOX-cardiomyopathy are scarce. Here, we identify the effect of forskolin (FSK) on DOX-induced-asymmetric-dimethylarginine (ADMA) accumulation in monocytoid
Externí odkaz:
https://doaj.org/article/51d3d12f765f4fca887b740777ea027c
Autor:
Ganesh Munuswamy-Ramanujan, Kanchana Mala, Vinnie Cheeran, Sandhiya Ramachandran, Swetha Loganathan, Vijay Raj, Mohankumar Ramasamy, Soniya Charles
Publikováno v:
Leukemia Research Reports, Vol 9, Iss, Pp 28-35 (2018)
Doxorubicin (DOX) is an antitumor drug, associated with cardiomyopathy. Strategies to address DOX-cardiomyopathy are scarce. Here, we identify the effect of forskolin (FSK) on DOX-induced-asymmetric-dimethylarginine (ADMA) accumulation in monocytoid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6f9f293076a7f61098f6052c8539e49
https://doi.org/10.1016/j.lrr.2018.02.001
https://doi.org/10.1016/j.lrr.2018.02.001
Autor:
Sandhiya, Ramachandran, Swetha, Loganathan, Vinnie, Cheeran, Soniya, Charles, Ganesh, Munuswamy-Ramanujan, Mohankumar, Ramasamy, Vijay, Raj, Kanchana, Mala
Publikováno v:
Leukemia Research Reports
Doxorubicin (DOX) is an antitumor drug, associated with cardiomyopathy. Strategies to address DOX-cardiomyopathy are scarce. Here, we identify the effect of forskolin (FSK) on DOX-induced-asymmetric-dimethylarginine (ADMA) accumulation in monocytoid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c95bcc1be89c35cf604fb7b85280ed5d
https://pubmed.ncbi.nlm.nih.gov/29892545
https://pubmed.ncbi.nlm.nih.gov/29892545
Autor:
Swetha Loganathan, Meenakshi Sundari, Sandhiya Ramachandran, B.S. Nayaker, Sowmya Thomas, Kanchana Mala
Publikováno v:
Diabetesmetabolic syndrome. 11
Polycystic ovarian syndrome (PCOS) is associated with multiple cardiovascular risk factors (CVRF) including endothelial dysfunction (ED) and presence of metabolic syndrome (MS). The probable reason suggested for elevated CVRF in PCOS is oxidative str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9efda189e2b8228bfbf1262c255df00
https://pubmed.ncbi.nlm.nih.gov/28711514
https://pubmed.ncbi.nlm.nih.gov/28711514